NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 338 filers reported holding NEOGENOMICS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $315,409 | -10.0% | 25,643 | +17.6% | 0.00% | -50.0% |
Q2 2023 | $350,422 | -7.7% | 21,806 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $379,642 | +112.8% | 21,806 | +12.9% | 0.00% | +100.0% |
Q4 2022 | $178,415 | +32.2% | 19,309 | +23.5% | 0.00% | 0.0% |
Q3 2022 | $135,000 | +6.3% | 15,635 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $127,000 | -33.2% | 15,635 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $190,000 | -64.4% | 15,635 | 0.0% | 0.00% | -66.7% |
Q4 2021 | $533,000 | -2.6% | 15,635 | +37.9% | 0.00% | 0.0% |
Q3 2021 | $547,000 | +6.8% | 11,340 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $512,000 | -6.4% | 11,340 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $547,000 | -21.7% | 11,340 | -12.6% | 0.00% | -25.0% |
Q4 2020 | $699,000 | +56.7% | 12,982 | +7.5% | 0.00% | +33.3% |
Q3 2020 | $446,000 | +19.3% | 12,081 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $374,000 | +40.6% | 12,081 | +25.4% | 0.00% | +50.0% |
Q1 2020 | $266,000 | +9.5% | 9,632 | +16.1% | 0.00% | 0.0% |
Q4 2019 | $243,000 | +120.9% | 8,298 | +43.6% | 0.00% | +100.0% |
Q3 2019 | $110,000 | -0.9% | 5,778 | +14.7% | 0.00% | 0.0% |
Q2 2019 | $111,000 | +7.8% | 5,039 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $103,000 | +41.1% | 5,039 | -13.4% | 0.00% | 0.0% |
Q4 2018 | $73,000 | -18.0% | 5,818 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $89,000 | +17.1% | 5,818 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $76,000 | +61.7% | 5,818 | 0.0% | 0.00% | – |
Q1 2018 | $47,000 | -9.6% | 5,818 | 0.0% | 0.00% | – |
Q4 2017 | $52,000 | +33.3% | 5,818 | +64.8% | 0.00% | – |
Q3 2017 | $39,000 | +21.9% | 3,530 | 0.0% | 0.00% | – |
Q2 2017 | $32,000 | +14.3% | 3,530 | 0.0% | 0.00% | – |
Q1 2017 | $28,000 | -6.7% | 3,530 | 0.0% | 0.00% | – |
Q4 2016 | $30,000 | -38.8% | 3,530 | -41.2% | 0.00% | -100.0% |
Q3 2016 | $49,000 | +2.1% | 6,001 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $48,000 | – | 6,001 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |